Although there are very few studies that examine its role in the skin, evidence from cisplatin- and benzopyrene-induced skin cytotoxicity experiments suggest that HMGB2 released from necrotic KCs triggers an immune response (Sharma et al., 2008), suggesting that a similar mechanism may occur in response to skin irritants. Here, HMGB2 is linked to dry eye syndrome.